Epidemiology & Director of Centre, Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham, Robert Aitken Building, Birmingham B15 2TY, UK.
Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL, USA.
Pediatr Clin North Am. 2020 Dec;67(6):1135-1154. doi: 10.1016/j.pcl.2020.07.006.
The authors' objective is to provide a brief update on recent advances in knowledge relating to subsequent primary neoplasms developing in survivors of childhood cancer. This includes a summary of established large-scale cohorts, risks reported, and contrasts with results from recently established large-scale cohorts of survivors of adolescent and young adult cancer. Recent evidence is summarized concerning the role of radiotherapy and chemotherapy for childhood cancer and survivor genomics in determining the risk of subsequent primary neoplasms. Progress with surveillance, screening, and clinical follow-up guidelines is addressed. Finally, priorities for future research are outlined.
作者的目的是提供与儿童癌症幸存者中继发原发性肿瘤相关的最新知识进展的简要更新。这包括对已建立的大型队列、报告的风险以及与最近建立的青少年和年轻成人癌症幸存者大型队列的结果进行的对比的总结。总结了近期关于儿童癌症放射治疗和化学疗法以及幸存者基因组学在确定继发原发性肿瘤风险中的作用的证据。讨论了监测、筛查和临床随访指南的进展。最后,概述了未来研究的重点。